What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature.
about
Multiple sclerosis and pregnancy; What a neurologist may be asked for?Missing and Possible Link between Neuroendocrine Factors, Neuropsychiatric Disorders, and MicrogliaSystematic review versus internet search: considerations about availability and reliability of medical information regarding pregnancy in women with multiple sclerosis.Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.Pregnancy in multiple sclerosis: a questionnaire study.Anesthetic management for parturients with neurological disorders.Longitudinal changes in serum proinflammatory markers across pregnancy and postpartum: effects of maternal body mass index.Multiple sclerosis and pregnancy: maternal considerations.Sex-related factors in multiple sclerosis susceptibility and progression.Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancyPregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.Birth hospitalization in mothers with multiple sclerosis and their newbornsOffspring Number Does Not Influence Reaching the Disability's Milestones in Multiple Sclerosis: A Seven-Year Follow-Up Study.Sex and gender issues in multiple sclerosis.Complex chimerism: pregnancy after solid organ transplantationPregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks.Glucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy.Sex influences in neurological disorders: case studies and perspectives.Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse.Female reproductive issues in multiple sclerosis.Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance.Current recommendations for multiple sclerosis treatment in pregnancy and puerperium.Long-term effects of exposure to disease-modifying drugs in the offspring of mothers with multiple sclerosis: a retrospective chart review.Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs.Multiple sclerosis and pregnancy in the 'treatment era'.An overview of pregnancy-related issues in patients with multiple sclerosis.Evaluation of a Decision Aid for Women with Epilepsy Who Are Considering Pregnancy: A Randomized Controlled Trial.Definitive childlessness in women with multiple sclerosis: a multicenter study.Treatment of multiple sclerosis during pregnancy - safety considerations.Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application.Multiple sclerosis in pregnancy: prevalence, sociodemographic features, and obstetrical outcomes.Obstetrical epidural and spinal anesthesia in multiple sclerosis.Multiple sclerosis and pregnancy prescriptions.Predictors and dynamics of postpartum relapses in women with multiple sclerosis.Is it correct for a woman with multiple sclerosis to forgo medication because she may become pregnant?Neuromyelitis optica and pregnancy.Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach.Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.Disease activity following pregnancy-related discontinuation of natalizumab in MS.Association of sex hormones and glucose metabolism with the severity of multiple sclerosis.
P2860
Q30428993-1264DABB-3F67-4D94-AAEE-C8C7AA5FCFE4Q30452038-66519DF7-C001-4E55-9D83-10CA481A0105Q30486029-B1C85FE8-5A08-4DF2-9725-8B7155A752DEQ31162052-1A31E2D7-1458-4E3F-B9D3-8B835C71C47CQ33717231-C748086E-18E0-42F4-A0BC-FB13CD96914BQ34236813-8F2BB902-21F0-404C-B778-1728D7962D9EQ34623190-2E5450AC-FE69-4AC8-B1C7-6AB795F88468Q34639869-9C6DAE93-B9BD-4107-BAA0-6A247467C1C6Q35619427-54526563-6CE4-4F6D-9C11-02920230952BQ36298897-FB07BF0A-F970-41FB-9C82-D1F88C7128EEQ36367612-C8A5652B-0998-4A0A-89C6-4FEF88B59BF5Q36661813-56CFF306-7F54-4DEA-9351-DFE503809021Q36667149-C2154720-4234-43C0-B00B-16E640910225Q36999743-9AAA113D-A958-409A-86D3-F59DE6DEFE5EQ37196104-886492BF-91DA-45CF-AB7A-5E15D0B3C418Q37547683-6162FC01-F8AF-4B31-8983-75DD27CCFFC1Q37589953-4CE2A4F8-2F00-4B8B-998A-CDE5261DF163Q37618512-A2218625-EEC3-4F09-B889-9E81089E1A68Q37729523-920D8E8F-D086-46E1-A5BD-0256F149728EQ38021743-FFA854B2-DA11-4B5C-B27E-3E1BDA5615D1Q38085336-124D94AB-740D-4538-9945-863C25422C61Q38125249-FC54B94A-3211-4BE7-97A7-C00DA154AED4Q38151555-64732206-2A14-4E18-B388-E1B6435C64CEQ38379249-D527D029-240D-426F-B05C-16DC90CC92EEQ38431744-E8AC94F8-5108-41E3-9D27-B625ECB0F31CQ38587675-CEF40053-6E8B-436E-B065-FAB0D91501E1Q38673714-F16120D0-3529-4EED-9767-A428BFAF6286Q38679960-83411825-2E58-4347-8FC9-5B55CAE513F3Q38883520-F936A7F1-8D15-4A02-BC40-67F0A16DE916Q38921991-477756BF-5C13-4175-A608-6A991705C5FBQ40351999-AB3F7794-DD5F-41A7-B70C-2868E573EB95Q44311224-3A7E9FC8-E1E9-4533-BA39-1857EBC08026Q45796699-964277D6-EB89-43A9-BC08-92E21B729879Q45832934-06503225-34F1-4F3A-83BA-CDD2EB66FB85Q46726626-CBB94C26-17D1-4873-BE9C-6C5F313E32E6Q46800143-81DA3FDA-2F04-42BB-8D37-64614A6A5E78Q47678330-26842055-E7B6-4CE2-99C7-75AB8643CE11Q48333424-F957BA33-4479-4A05-9EF6-1CE57EA4D54EQ49590553-99B14E02-A0CB-461C-B88E-5BD5B18D37DBQ51296580-F5843FB1-3A23-4E34-ADD2-EBFE4EFA02E3
P2860
What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
What can we really tell women ...... ta-analysis of the literature.
@en
What can we really tell women ...... ta-analysis of the literature.
@nl
type
label
What can we really tell women ...... ta-analysis of the literature.
@en
What can we really tell women ...... ta-analysis of the literature.
@nl
prefLabel
What can we really tell women ...... ta-analysis of the literature.
@en
What can we really tell women ...... ta-analysis of the literature.
@nl
P2093
P2860
P921
P1476
What can we really tell women ...... ta-analysis of the literature.
@en
P2093
A Finkelsztejn
F M Paschoal
J B B Brooks
P2860
P304
P356
10.1111/J.1471-0528.2011.02931.X
P577
2011-03-15T00:00:00Z